- Home
- DYN vs INDV Comparison
DYN vs INDV Comparison
Compare DYN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- INDV
- Stock Information
- Founded
- DYN 1984
- INDV 1994
- Country
- DYN United States
- INDV United States
- Employees
- DYN N/A
- INDV N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- DYN Health Care
- INDV Health Care
- Exchange
- DYN Nasdaq
- INDV Nasdaq
- Market Cap
- DYN 1.9B
- INDV 1.9B
- IPO Year
- DYN 2020
- INDV N/A
- Fundamental
- Price
- DYN $14.22
- INDV $24.98
- Analyst Decision
- DYN Strong Buy
- INDV Strong Buy
- Analyst Count
- DYN 14
- INDV 4
- Target Price
- DYN $34.93
- INDV $23.75
- AVG Volume (30 Days)
- DYN 2.4M
- INDV 2.1M
- Earning Date
- DYN 07-28-2025
- INDV 10-23-2025
- Dividend Yield
- DYN N/A
- INDV N/A
- EPS Growth
- DYN N/A
- INDV N/A
- EPS
- DYN N/A
- INDV 0.42
- Revenue
- DYN N/A
- INDV $1,173,000,000.00
- Revenue This Year
- DYN N/A
- INDV N/A
- Revenue Next Year
- DYN N/A
- INDV $3.00
- P/E Ratio
- DYN N/A
- INDV $59.99
- Revenue Growth
- DYN N/A
- INDV 2.27
- 52 Week Low
- DYN $6.36
- INDV $7.33
- 52 Week High
- DYN $37.08
- INDV $25.00
- Technical
- Relative Strength Index (RSI)
- DYN 73.48
- INDV 80.77
- Support Level
- DYN $13.03
- INDV $23.59
- Resistance Level
- DYN $13.85
- INDV $25.00
- Average True Range (ATR)
- DYN 0.64
- INDV 0.68
- MACD
- DYN 0.04
- INDV -0.18
- Stochastic Oscillator
- DYN 95.55
- INDV 98.96
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.